You are required to be logged in to access the full website
User Name: Password:
Click here if you have forgotten your username or password
  • Home
  • Latest News
  • Search
  • About M2 Pharma
  • Subscribe
Business & Finance
Generics
Therapy Areas
Policy & Regulation
Research & Development
People
Therapy Areas: Cardiovascular
New Study Finds That Masimo PVi Reliably Predicted Fluid Responsiveness in Young Children Undergoing Neurosurgery
Login
Username:

Password:


Related Headlines

Clario partners with AWS on advancing clinical data analysis with generative AI

Langhua Pharmaceutical passes US FDA's on-site inspection

Abbott receives CE Mark for Volt Pulsed Field Ablation System to treat atrial fibrillation

Ionis announces partnership expansion with Sobi for global olezarsen commercialisation

Sermonix Pharmaceuticals collaborates with Regor Therapeutics Group on development of new breast cancer treatments

BioCardia secures Japanese patent for Helix biotherapeutic delivery system

Doer Bio completes DR10624phase two clinical study enrolment

Kancera and Recardio sign letter of intent for licensing agreement

Novo Nordisk launches NovoCare Pharmacy to reduce Wegovy costs and expand access

Redx Pharma reports positive Phase 1 results for RXC008 in fibrostenotic Crohn's disease

Hims & Hers acquires Trybe Labs to expand at-home testing capabilities

TriNetX and Fujitsu form joint venture to enhance clinical research in Japan

Novartis to acquire Anthos Therapeutics in USD925m deal to expand cardiovascular pipeline

BrainCool secures market approval for BrainCool System in Malaysia

Roche's blood test measuring Lp(a) in molar units receives US FDA 510(k) approval

Home | Business & Finance | Generics | Therapy Areas | Policy & Regulation | Research & Development | People | Search | About M2 Pharma | Subscribe
Copyright © 2025